Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus

R Germi, JM Crance, D Garin, J Guimet, H Lortat-Jacob…�- Virology, 2002 - Elsevier
Dengue virus type 2 and Yellow fever virus are arthropod-borne flaviviruses causing
hemorrhagic fever in humans. Identification of virus receptors is important in understanding�…

Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption

R Germi, JM Crance, D Garin, J Guimet…�- Journal of medical�…, 2002 - Wiley Online Library
The initial binding of Hepatitis C virus (HCV) to the cell membrane is a critical determinant of
pathogenesis. Two putative HCV receptors have been identified, CD81 and low‐density�…

[HTML][HTML] Virological markers in Epstein–Barr virus-associated diseases

…, J Andreani, M Habib, O Epaulard, P Morand, R Germi�- Viruses, 2023 - mdpi.com
Epstein–Barr virus (EBV) is an oncogenic virus infecting more than 95% of the world's
population. After primary infection—responsible for infectious mononucleosis in young�…

Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease

H Perron, R Germi, C Bernard…�- Multiple sclerosis�…, 2012 - journals.sagepub.com
Background: The envelope protein from multiple sclerosis (MS) associated retroviral
element (MSRV), a member of the Human Endogenous Retroviral family 'W'(HERV-W)�…

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

…, M Essig, JP Rerolle, S Cotin, R Germi…�- Journal of�…, 2010 - academic.oup.com
Objectives Cytomegalovirus (CMV) drug resistance is a therapeutic challenge in the
transplant setting. No longitudinal cohort studies of CMV resistance in a real-life setting have�…

Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis

…, P Pavese, M Baccard, R Germi…�- The Journal of�…, 2005 - academic.oup.com
Abstract Epstein-Barr virus (EBV) DNA loads in peripheral blood mononuclear cells
(PBMCs), plasma, and saliva, as well as infectivity of the virus in saliva, were evaluated in 20�…

[HTML][HTML] Main targets of interest for the development of a prophylactic or therapeutic Epstein-Barr virus vaccine

…, J Lupo, M Buisson, P Morand, R Germi�- Frontiers in�…, 2021 - frontiersin.org
Epstein-Barr virus (EBV) is one of the most widespread viruses in the world; more than 90%
of the planet's adult population is infected. Symptomatic primary infection by this�…

Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus

R Germi, C Mariette, S Alain, J Lupo, A Thiebaut…�- Antiviral research, 2014 - Elsevier
Cytomegalovirus (CMV) strains resistant to ganciclovir, cidofovir and/or foscarnet were
genotypically and phenotypically characterised in two haematopoietic stem cell transplant�…

[HTML][HTML] Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000–2016

G Fourcade, R Germi, F Guerber, J Lupo, M Baccard…�- PLoS�…, 2017 - journals.plos.org
Background According to rare studies, the age at EBV primary infection (PI) has recently
risen in some developed countries. A later age at infection is generally considered a risk�…

[HTML][HTML] An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes

…, K R�ant, M Normand, M Seffals, J Dimier, R Germi…�- JCI insight, 2017 - ncbi.nlm.nih.gov
Human endogenous retroviruses (HERVs), remnants of ancestral viral genomic insertions,
are known to represent 8% of the human genome and are associated with several�…